Ultragenyx Pharmaceutical News

Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Crombez Eric

Apr 19 16:40 ET

Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Huizenga Theodore Alan

Apr 18 18:07 ET

Ultragenyx Pharmaceutical | 8-K: Current report

Apr 15 08:08 ET

Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Kassberg Thomas Richard

Mar 12 13:43 ET

Ultragenyx Pharmaceutical | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 11 18:43 ET

Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director Fust Matthew K

Mar 11 12:57 ET

Ultragenyx Pharmaceutical | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 7 16:16 ET

Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Horn Howard

Mar 5 20:24 ET

Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Parschauer Karah Herdman

Mar 5 20:24 ET

Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Kassberg Thomas Richard

Mar 5 20:24 ET

Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Pinion John Richard

Mar 5 20:20 ET

Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Huang Dennis Karl

Mar 5 20:19 ET

Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Huizenga Theodore Alan

Mar 5 20:14 ET

Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Crombez Eric

Mar 5 20:14 ET

Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Harris Erik

Mar 5 20:09 ET

Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer KAKKIS EMIL D

Mar 5 20:09 ET

Ultragenyx Pharmaceutical | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Feb 21 17:10 ET

Ultragenyx Pharmaceutical | 10-K: Annual report

Feb 21 16:07 ET

Ultragenyx Pharmaceutical | 8-K: Ultragenyx Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update

Feb 15 16:09 ET

Ultragenyx Pharmaceutical | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. ROWE PRICE ASSOCIATES, INC.(4.2%)

Feb 14 10:16 ET